Basic Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Feb 7, 2022; 28(5): 547-569
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.547
Table 4 Clinicopathological relevance of connective tissue growth factor high and low expression status determined by immunohistochemistry in colorectal cancer patients
Characteristics
Low expression (n = 27)
High expression (n = 44)
Odds ratio (95%CI)
P value
Chi2
Age
< 506 (28.57)15 (71.43)Referent
≥ 5021 (42.00)29 (58.00)1.8 (0.5-6.6)0.281.13
Gender
Male11 (28.95)27 (71.05)Referent
Female16 (48.48)17 (51.52)2.3 (0.8-6.9)0.092.86
Dwelling
Rural19 (40.43)28 (59.57)Referent
Urban8 (33.33)16 (66.67)0.7 (0.2-2.2)0.560.33
Social class
Low10 (45.45)12 (54.55)Referent
Middle and high17 (34.69)32 (65.31)1.5 (0.5-5.0)0.380.74
Family history
Yes7 (35.00)13 (65.00)Referent
No20 (39.22)31 (60.78)0.8 (0.2-2.7)0.740.10
Smoking status
Yes10 (25.00)30 (75.00)Referent
No17 (54.84)14 (45.16)3.6 (1.2-11.3)0.010a6.61
Lifestyle
Active12 (38.71)19 (61.29)Referent
Sedentary15 (37.50)25 (62.50)0.9 (0.3-2.8)0.920.01
Salt tea intake
Yes24 (36.92)41 (63.08)Referent
No3 (50.00)3 (50.00)1.7 (0.2-13.6)0.530.41
Red meat consumption
Yes23 (38.98)36 (61.02)Referent
No4 (33.33)8 (66.67)0.8 (0.15-3.3)0.710.13
Sundried vegetables
Yes19 (39.58)29 (60.42)Referent
No8 (34.78)15 (65.22)0.8 (0.2-2.5)0.700.15
Source of drinking water
Tap water (R)20 (43.48)26 (56.52)Referent
Tap water (L)1 (14.29)6 (85.71)0.2 (0.004-2.06)
Others1 6 (33.33)12 (66.67)0.6 (0.2-2.3)0.292.41
Pickles
Yes16 (59.26)25 (56.82)Referent
No11 (40.74)19 (43.18)0.9 (0.3-2.6)0.840.04
Pesticide exposure
Yes15 (55.56)18 (40.91)Referent
No12 (44.44)26 (59.09)0.5 (0.2-1.6)0.231.4
Junk food consumption
Yes0 (0)5 (100)Referent
No27 (40.91)39 (59.09)0 (0-1.1)0.073.30
Site of tumor
Colon11 (30.56)25 (69.44)Referent
Rectum12 (60.00)8 (40.00)3.4 (0.9-12.5)
Rectosigmoid4 (26.67)11 (73.33)0.8 (0.1-3.7)0.065.81
Tumor differentiation
Well14 (77.78)4 (22.22)Referent
Moderate12 (26.09)34 (73.91)0.1 (0.02-0.4)
Poor1 (14.29)6 (85.71)0.05 (0.01-0.6)0.000a16.52
Invasion depth
T17 (25.93)1 (2.27)Referent
T212 (44.44)10 (22.73)0.2 (0.003-1.8)0.001a17.30
T37 (25.93)24 (54.550)0.04 (0.01-0.4)
T41 (3.70)9 (20.45)0.01 (0.01-0.40)
T1 + T219 (70.37)11 (25.00)
T3 + T48 (29.63)33 (75.00)0.14 (0.04-0.4)0.000a14.11
TNM staging
I18 (66.67)7 (15.91)Referent
II7 (25.93)18 (40.91)0.1 (0.03-0.6)0.000a20.7
III2 (7.41)16 (36.36)0.05 (0.01-0.3)
IV0 (0)3 (6.820)0 (0-0.6)
I + II25 (92.59)25 (56.82)
III + IV2 (7.41)19 (43.18)0.12 (0.01-0.5)0.001a10.31
Tumor grade
114 (77.78)4 (22.22)Referent
212 (26.09)34 (73.91)0.1 (0.02-0.4)
31 (14.29)6 (85.71)0.05 (0.01-0.6)0.000a16.52
DUKE stage
A4 (80.00)1 (20.00)Referent
B21 (47.73)23 (52.27)0.2 (0.004-2.6)
C2 (9.09)20 (90.91)0.02 (0.014-0.5)0.001a13.3
Node status
025 (49.02)26 (50.98)Referent
1 and 22 (10.00)18 (90.00)0.1 (0.01-0.6)0.002a9.30
LVI
Present17 (31.48)37 (68.52)Referent
Absent10 (58.82)7 (41.18)0.3 (0.1-1.13)0.043a4.11
PNI
Present1 (6.67)14 (93.33)Referent
Absent26 (46.43)30 (53.57)0.1 (0.002-0.6)0.020a5.42
TALNR
Present24 (38.71)38 (61.29)Referent
Absent3 (33.33)6 (66.67)0.8 (0.1-4.1)0.750.09
Necrosis seen
Yes24 (47.06)27 (52.94)Referent
No3 (15.00)17 (85.00)0.2 (0.03-0.82)0.012a6.21
Recurrence
Yes1 (8.33)11 (91.67)Referent
No26 (44.07)33 (55.93)0.11 (0.012-0.9)0.020a5.40
Vital status
Alive26 (39.39)40 (60.61)Referent
Death1 (20.00)4 (80.00)0.4 (0.07-4.2)0.3890.74